CMO
CMO collaborates on production of drug product of Mepsevii
Contract manufacturing organisation (CMO) and aseptic fill and finish services expert, Rentschler Fill Solutions, has announced its collaboration with Ultragenyx Pharmaceutical for the production of the drug product of the injectable Mepsevii more
Cobra Biologics and Symbiosis granted £1.9 million from Innovate UK
International CDMO of biologics and pharmaceuticals, Cobra Biologics, and CMO specialising in sterile fill finish, Symbiosis Pharmaceutical Services, have been awarded a collaborative grant of £1.9 million from Innovate UK. more
Winning formula: Differentiation strategies that are the keys to success for CMOs
Focusing on the keys to success for contract drug manufacturers, Arnaud Sergent, Serge Hovsepian, Nohmie Ben Rekassa and Ben Faircloth from L.E.K. Consulting detail the differentiation strategies that have proven themselves in the marketplace more
Universal Appeal: Producing and packaging pharmaceuticals for global customers
R-Pharm Germany is a CMO producing and packaging pharmaceuticals for customers in more than 150 countries. more
Vantage Consulting Group joins PBOA
Vantage Consulting Group, a manufacturing automation expert, has joined the Pharma & Biopharma Outsourcing Association (PBOA). It will be the first systems integrator to join the association. more
AMRI receives CMO Leadership Awards
AMRI has been recognised for its excellence as a CMO and has been honoured as part of the Life Science Leader’s 2017 CMO Leadership Awards in five categories — capabilities, compatibility, expertise, quality and reliability. more
The good, the bad, and the Donald: Trump's implications on pharma
Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities, say the experts. more
Strict but supple: The potential changes industrial automation can offer
Robert Harrison, pharmaceutical industry manager of industrial software expert COPA-DATA, explains how industrial automation solutions could change the face of biopharmaceutical manufacturing in the years to come. more
